(Q48723145)

15 February 2018

title

Follicular growth and oocyte maturation in GnRH agonist and antagonist protocols for in vitro fertilisation and embryo transfer. (English)

1 reference

15 February 2018

author

Paolo Trerotoli

7

1 reference

15 February 2018

author name string

Raffaella Depalo

1

1 reference

15 February 2018

Filomenamila Lorusso

2

1 reference

15 February 2018

Marcella Palmisano

3

1 reference

15 February 2018

Emma Bassi

4

1 reference

15 February 2018

Ilaria Totaro

5

1 reference

15 February 2018

Margherita Vacca

6

1 reference

15 February 2018

Paola Masciandaro

8

1 reference

15 February 2018

Luigi Selvaggi

9

1 reference

15 February 2018

publication date

1 May 2009

1 reference

15 February 2018

Gynecological Endocrinology

published in

1 reference

15 February 2018

volume

25

1 reference

15 February 2018

issue

5

1 reference

15 February 2018

page(s)

328-334

1 reference

15 February 2018

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

The role of gonadotropin-releasing hormone antagonists in in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

GnRH agonists, antagonists, and assisted conception

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

A randomised study of GnRH antagonist (cetrorelix) versus agonist (busereline) for controlled ovarian stimulation: effect on safety and efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Thyroid disease and other endocrine disorders in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles--a prospective, randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Comparison of multiple dose GnRH antagonist and minidose long agonist protocols in poor responders undergoing in vitro fertilization: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

GnRH agonist versus GnRH antagonist in poor ovarian responders: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Are GnRH antagonists comparable to agonists for use in IVF?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Embryo implantation and GnRH antagonists: ovarian actions of GnRH antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Effects of gonadotrophin-releasing hormone agonists on human ovarian steroid secretion in vivo and in vitro-results of a prospective, randomized in-vitro fertilization study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

GnRH antagonist in assisted reproduction: a Cochrane review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Flexible GnRH antagonist versus flare-up GnRH agonist protocol in poor responders treated by IVF: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590802617762

10.1080/09513590802617762

21 January 2018

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018